Sociodemographic features of organophosphate poisonings and the relationship between time of pralidoxime administration and mortality

Yıl 2013, Cilt: 40 Sayı: 4, 549 - 554, 01.12.2013

Mehmet Nezir Güllü Ali Kemal Kadiroğlu Murat Orak Mehmet Üstündağ Mehmet Emin Yılmaz

https://doi.org/10.5798/diclemedj.0921.2013.04.0331

Öz

Objective: Organophosphates are commonly used in agriculture and mostly lead to intoxication. In this study, we examined the sociodemographic features, clinical findings, and the relationship between time to treatment with pralidoxime and mortality in patients with organophosphate poisoning treated in our clinic. Methods: We retrospectively examined hospital records of 179 patients who were managed for organophosphate poisoning in our clinic, between January 2001 and November 2009. Sociodemographic data, clinical findings, laboratory results, complications during follow-up, and outcomes were recorded. The patients were grouped as died and survived, and comparison of sociodemographic and clinical features, laboratory results, and treatment outcomes were performed. Results: Among 179 patients, 133 (74.3%) were female, 46 (25.6%) were male and mean age was 27.1+11.7 years. Fifteen (8.3%) patients died. Illiteracy rate among those who died was 66.6%, while it was 30.4% in those who survived. Among those who died, 13 (86.6%) had nicotinic and 14 (93.3%) had CNS signs. Assessment of cases by the time to PAM administration revealed mortality rates of 4.47% (n=6), 19.4 % (n=7), and 22.2% (n=2) for the first 3 hours (n= 134), 3-6 hours (n=36), and after 6 hours (n=9), respectively. Conclusion: A great majority of patients presenting with organophosphate poisoning were of low educational status, which was linked with mortality, indicates the importance of education. In addition, mortality rate was lower in patients who were administered PAM at an earlier period in the treatment process, suggesting the role of early PAM administration in reducing mortality.

Anahtar Kelimeler

Organophosphate, pralidoxime, mortality

Organofosfat zehirlenmelerinin sosyodemografik özellikleri ve pralidoksim verilme zamanı ile mortalite arasındaki ilişki

Öz

Amaç: Organofosfatlı ilaçlar tarım sektöründe sıklıkla kullanılmaktadır ve ilaç zehirlenmelerinde önemli bir yer tutmaktadır. Bu çalışmada, kliniğimizde takip edilen organofosfat zehirlenme vakalarının sosyodemografik verileri, klinik bulguları ve pralidoksim (PAM) tedavisine başlanma zamanı ile mortalite arasındaki ilişki araştırıldı. Yöntemler: Çalışma kapsamında Ocak 2001 - Kasım 2009 tarihleri arasında Dicle Üniversitesi Tıp Fakültesi İç Hastalıkları Kliniği\'nde organofosfat zehirlenmesi nedeni ile takip edilen 179 hastanın dosyaları geriye dönük olarak incelendi. Hazırlanan standart çalışma formlarına; sosyodemografik veriler, klinik bulgular, laboratuvar verileri, takip esnasında gelişen komplikasyonlar ve tedavi sonuçları kaydedildi. Hastalar ölen ve sağ kalan hastalar şeklinde gruplandırılarak sosyodemografik, klinik, laboratuvar sonuçları ve tedavi sonuçları karşılaştırıldı. Bulgular: Çalışmaya alınan 179 hastanın 133 (%74,3)\'ü kadın, 46 (%25,6)\'sı erkek ve yaş ortalamaları 27,13+11,68 idi. Hastalarımızın 15'i (% 8,3) öldü. Ölen hastalarımızda okur-yazar olmama oranı % 66,6 iken sağ kalan hastalarda bu oran %30,4 idi. Ölen hastaların 13'ünde (% 86,6) nikotinik, 14'ünde (% 93,3) SSS bulguları görülürken, sağ kalanların 76'sında (% 46,3) nikotinik ve 62'sinde (% 37,8) SSS bulguları görüldü. PAM verilme zamanına göre hastalar değerlendirildiğinde; ilk 3 saatte (n=134), 3-6 saatte (n=36) ve 6 saatten sonra (n=9) olup, bu saatlere göre PAM tedavisi verilenlerin mortalite oranları sırasıyla; % 4,47 (n=6), % 19,4 (n=7), % 22,2 (n=2) olduğu tespit edildi. Sonuçlar: Organofosfat zehirlenmesi ile başvuran hastaların büyük çoğunluğunun eğitim düzeyinin düşük olup mortalite ile ilişkili bulunması eğitimin önemini göstermektedir. Ayrıca PAM tedavisi erken verilenlerde mortalite oranı daha düşük bulunmuş olup, PAM tedavisine erken başlanması mortaliteyi azaltmada önemlidir.

Anahtar Kelimeler

Organofosfat, pralidoksim, mortalite

Kaynakça

• Sungur M, Guven M. Intensive care management of organo- phosphate insecticide poisoning. Crit Care 2001;5:211-215.
• Kwong TC. Organophosphate pesticides: Biochemistry and clinical toxicology. Ther Drug Monit 2002;24:144-149.
• Robey WC, Meggs WJ. Insecticides, herbicides and roden- ticides. In: Tintinalli JE, Kelen GD, Stapczynski JS, eds. Emergency Medicine: a comprehensive study guide. 6th Edn. McGraw-Hill Co, New York, 2004;1134-1143.
• Mortenson ML. Manegament of acut chilhood poisoning caused by selected insectiside and herbicid. Pediatrics Clin- ics of Nourth America 1986;33:421-444.
• Karalliedde L. Organophosphorus poisoning and anaesthe- sia. Anaesthesia 1999;54:1073-1088.
• Karalliedde L, Senanayake N, Ariaratnam A. Acute organo- phosphorus insecticide poisoning during pregnancy. Hum Toxicol 1988;7:363-364.
• Hayes WJ. Organophosphate insecticides. In pesticides stud- ied in man. Edited by Hayes WJ. Baltimore, MD: Williams &Wilkins; 1982:285-315.
• Hayes MM, Van der Westhuizen NG, Gelfand M. Organo- phosphate poisoning in Rhodesia. S Afr Med J 1978; 54:230–234.
• Sahin HA, Sahin I, Arabaci F. Sociodemographic factors in organo-phosphate poisonings: A prospective study. Hum Exp Toxicol 2003;22:349-353.
• Kara IH, Guloglu C, Karabulut A, et al. Sociodemographic, clinical, and laboratory features of cases of organic phos- phorus intoxication who attended the Emergency Depart- ment in the Southeast Anatolian Region of Turkey. Environ Res 2002;88:82-88.
• Lin TJ, Walter FG, Hung DZ, et al. Epidemiology of or- ganophosphate pesticide poisoning in Taiwan. Clin Toxicol 2008;46:794-801.
• Yurumez Y, Durukan P, Yavuz Y, et al. Acute organophos- phate poisoning in university hospital emergency room pa- tients. Intern Med 2007;46:965-969.
• Agarwal SB. A clinical, biochemical, neurobehavioural, and sociopsychological study of 190 patients admitted to hospital as a result of acute organophosphorous poisoning. Environ Res 1993;62:63-70.
• Namba T, Nolte CT, Jackrel J, Grob D. Poisoning due to organophosphate insecticides. Acute and chronic manifes- tations. Am J Med 1971;50:475–492.
• Haddad L, Winchester J. Clinical Management of Poisoning and Overdose. Philadelphia, PA: WB Saunders, 1983.
• Nouira S, Abroug F, Elatrous S, Boujdaria R, Bouchoucha S. Prognostic value of serum cholinesterase in organophos- phate poisoning. Chest 1994;106:1811-1814.
• Al B, Güllü MN, Küçüköner M, ve ark. Dicle Üniversitesi Tıp Fakültesi acil servisine organofosfat zehirlenmeleri ile başvuran hastaların demografik özellikleri. Tıp Araştırma- ları Dergisi 2006;4:5-13.
• Ozturk MA, Kelestimur F, Kurtoglu S, ve ark. Anticho- linesterase poisoning in Turkey-clinical, laboratory and radiologic evaluation of 269 cases. Hum Exp Toxicol 1990;9:273-279.
• Ellenhorn MJ, Barcebux DG. Pesticides. In: Ellenhorn’s medical toxicology:Diagnosis and treatment of human poi- soning. Ellenhorn MJ, Ed. Lippincott Williams & Wilkins, Portland, 1996:1614-1663.
• Eddleston M, Dawson A, Karalliedde L, et al. Early man- agement after self-poisoning with an organophosphorus or carbamate pesticide–a treatment protocol for junior doc- tors. Crit Care 2004; 8:391-397.
• Peter JV, Cherian AM. Organic insecticides. Anaesth Inten- sive Care 2000; 28:11–21.
• Eddleston M, Szinicz L, Eyer P, Buckley N. Oximes in acute organophosphorus pesticide poisoning: a systematic review of clinical trials. QJM 2002;95:275-283.
• Lotti M. A critical review of oximes in the treatment of acute organophosphate poisoning. J Toxicol Clin Toxicol 2003;41:440–441.
• Sarıtaş ve ark. Organofosfat ve karbamat zehirlenmeleri. EAJM 2007;39:55-59.
• Johnson MK, Vale JA, Marrs TC, Meredith TJ. Pralidoxime for organophosphorus poisoning [letter]. Lancet 1992;340: 64.
• Johnson MK, Jacobsen D, Meredith TJ, et al. Evaluation of antidotes for poisoning by organophosphorus pesticides. Emergency Medicine 2000;12: 22–37.
• De Silva HJ, Wijewickrema R, Senanayake N. Does prali- doxime affect outcome of management in acute organo- phosphorus poisoning? Lancet 1992;339:1136-1141.
• Durham WF,Hayes WJ. Organic phophorus poisoning and its therapy. Arch Environ Health 1962;5:21-53.
• Sanderson DM. Treament of poisoning by anticholinester- ase insecticides in the rat. J Pharm Pharmacol 1961;13:435- 39.
• Peter JV, Moran JL, Graham P. Oxime therapy and outcomes in human organophosphate poisoning: an evaluation using meta-analytic techniques. Crit Care Med 2006;34:502-510.
• Chung SN , Aggarwal N, Dabla S, Chhabra B. Comparative evaluation of “Atropine Alone” and “ Atropine with Prali- doxime (PAM) in the management of organophosphorus poisoning. JIACM 2005; 6:33-37.
• Duval G, Rakuer JM, Tilland D, et al. Acute poisoning bio- insecticides with anticholinesteraseactivity. Evaluation of the efficacy of a cholinesterase reactivator, pralidoksime. J Toxicol Clin Toxicol 1991;11:51-58.
• Peter JV,Moran JL,Graham P. Oxime therapy and outcomes in human organophosphate poisoning. Crit Care Med 2006;34:502-510.
• Willems JL, Langenberg JP,Vestraete AG, et al. Plasma con- centrations of pralidoxime methylsulphate in organopfos- phorus poisoned patients. Arch Toxicol 1992;66:260-266.
• Santos RP, Cavalare MJ, Puga FR, et al. Protective effect of early and late administration of pralidoxime against or- ganophosphate muscle necrosis. Ecotoxicol Enviromental Safe 2002; 53:48-51.